Prognostic value of total tumor volume with 68Ga DOTATOC PET/CT in predicting response to 177-Lu-DOTATOC treatment in metastatic well-differentiated neuroendocrine tumors (NETs)

被引:0
|
作者
Vega-Zolano, Elizabeth
Ruiz, Erika
Caderillo-Ruiz, German
Diaz, Consuelo
Herrera, Marytere
Torres Agredo, Liliana Patricia
Soldevilla-Gallardo, Irma
Michel-Sanchez, Emiliano
Garcia-Perez, Francisco Osvaldo
机构
[1] Inst Nacl Cancerolgia, Mexico City, DF, Mexico
[2] Inst Nacl Cancerol, Gastrointestinal Oncol Unit, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Mexico City, Mexico
[4] Inst Nacl Cancerol, Bogota, Colombia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16248
引用
收藏
页数:1
相关论文
共 50 条
  • [1] [68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The "Theragnomics" Concept
    Laudicella, Riccardo
    Comelli, Albert
    Liberini, Virginia
    Vento, Antonio
    Stefano, Alessandro
    Spataro, Alessandro
    Croce, Ludovica
    Baldari, Sara
    Bambaci, Michelangelo
    Deandreis, Desiree
    Arico', Demetrio
    Ippolito, Massimo
    Gaeta, Michele
    Alongi, Pierpaolo
    Minutoli, Fabio
    Burger, Irene A.
    Baldari, Sergio
    CANCERS, 2022, 14 (04)
  • [2] Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from 68Ga-DOTATOC PET/CT in Well-Differentiated Neuroendocrine Tumors
    Thuillier, Philippe
    Liberini, Virginia
    Grimaldi, Serena
    Rampado, Osvaldo
    Gallio, Elena
    De Santi, Bruno
    Arvat, Emanuela
    Piovesan, Alessandro
    Filippi, Roberto
    Abgral, Ronan
    Molinari, Filippo
    Deandreis, Desiree
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (07) : 1014 - 1020
  • [3] 68Ga DOTATOC PET/CT for treatment response of Peptide Receptor Radionuclide Therapy using 177Lu and 90Y-DOTATOC
    Finocchiaro, D.
    Grassi, E.
    Fioroni, F.
    Castellani, G.
    Lanconelli, N.
    Versari, A.
    Filice, A.
    Iori, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S288 - S288
  • [4] False-Negative Neuroendocrine Tumor Identified With 68Ga-DOTATOC PET/CT: A Case of Well-Differentiated Somatostatinoma
    Moreau, Aurelie
    Chaouat, Charlotte
    Walter, Thomas
    Dupre, Aurelien
    Kryza, David
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (08) : 764 - 766
  • [5] SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors
    Kratochwil, C.
    Stefanova, M.
    Mavriopoulou, E.
    Holland-Letz, T.
    Dimitrakopoulou-Strauss, A.
    Afshar-Oromieh, A.
    Mier, W.
    Haberkorn, U.
    Giesel, F. L.
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (03) : 313 - 318
  • [6] Prognostic value of whole-body PET volumetric parameters extracted from 68Ga-DOTATOC-PETICT in well-differentiated neuroendocrine tumors
    Thuillier, P.
    Liberini, V
    Grimaldi, S.
    Rampado, O.
    Gallo, E.
    De Santi, B.
    Ceci, F.
    Arvat, E.
    Piovesan, A.
    Filippi, R.
    Molinari, F.
    Deandreis, D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 198 - 198
  • [7] SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors
    C. Kratochwil
    M. Stefanova
    E. Mavriopoulou
    T. Holland-Letz
    A. Dimitrakopoulou-Strauss
    A. Afshar-Oromieh
    W. Mier
    U. Haberkorn
    F. L. Giesel
    Molecular Imaging and Biology, 2015, 17 : 313 - 318
  • [8] Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
    Philippe Thuillier
    David Bourhis
    Jean Philippe Metges
    Romain Le Pennec
    Karim Amrane
    Ulrike Schick
    Frédérique Blanc-Beguin
    Simon Hennebicq
    Pierre-Yves Salaun
    Véronique Kerlan
    Nicolas Karakatsanis
    Ronan Abgral
    Scientific Reports, 11
  • [9] Tumor-to-Liver Ratio of Ga-68-DOTATOC PET/CT as a Prognostic Parameter in Metastatic, Well-Differentiated Gastroenteropancreatic-Neuroendocrine Tumor Patients Who Received Lanreotide Therapy
    Kim, Y., I
    Yoo, C.
    Ryoo, B. Y.
    Ryu, J. S.
    NEUROENDOCRINOLOGY, 2020, 110 : 260 - 260
  • [10] Prognostic value of whole-body PET volumetric parameters extracted from 68Ga-DOTATOC-PET/CT in well- differentiated neuroendocrine tumors
    Thuillier, P.
    Liberini, V.
    Grimaldi, S.
    Rampado, O.
    Gallio, E.
    De Santi, B.
    Arvat, E.
    Piovesan, A.
    Filippi, R.
    Molinari, F.
    Deandreis, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S139 - S140